BUFFALO, N.Y., Sept. 12, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (XXII) (Nasdaq: XXII), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and ...
BUFFALO, N.Y., Oct. 26, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (XXII) (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving health with reduced nicotine ...
Expansion in 2026 Forecasted to Exceed 5,000 Retail Outlets Nationwide as Consumers Demonstrate Interest in VLN® BrandsVLN® Remains the Only ...
BUFFALO, N.Y., June 23, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and ...
BUFFALO, N.Y., July 13, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and ...
Balance sheet strength, ended 2025 with $7.1 million in cash and debt free, supports transition to growthContinued VLN® commercial expansion ...
Smoker Friendly will offer VLN reduced nicotine cigarettes in partnership with 22nd Century Group, launching new product lines in 2025. 22nd Century Group, Inc. has announced a partnership with Smoker ...
BUFFALO, N.Y., July 12, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and ...
22nd Century Group, Inc. has been highlighted in a Washington Post article discussing new FDA policies aimed at reducing the health risks associated with smoking, particularly through the ...
22nd Century Group, Inc. beats earnings expectations. Reported EPS is $-48.96, expectations were $-648. Operator: Welcome to 22nd Century Group’s Fourth Quarter and Full Year 2024 Conference Call and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results